Related by context. All words. (Click for frequent words.) 57 Antiviral Therapy 56 Sipuleucel T 55 Abstract Number 54 Scientific Poster Session 54 MR Angiography 53 Activator CK # 53 Placebo Controlled Study 53 Thymosin 53 Placebo Controlled Trial 52 TH PO# 52 Poster Discussion 52 ASCO abstract 52 ASCO GI 52 SA FC# 52 Neoplasms 52 Lenalidomide 51 Treatment Regimens 51 SABCS 51 Cytotoxicity 51 pT2 50 ECCMID 50 Meta Analysis 50 Induction Chemotherapy 50 Interferon Alfa 50 Supplemental Figure 50 Allogeneic 50 Podium Presentation 50 Progenitor Cells 50 Pooled Analysis 50 multidetector row 50 Natalizumab 50 Hepatocellular Carcinoma 50 Prostatic 50 Oral Presentation 50 ASCO Abstract 50 Poster Presentations 50 Chemoradiation 49 Polymorphism 49 doi #.#/fj.#-# 49 Late Breaker 49 fosbretabulin 49 Treated Patients 49 #F FDG PET 49 entitled Synergistic 49 Peripheral Arterial 49 Subcutaneous 49 Immune Mediated 49 Risk Stratification 49 Suppl. 49 Thrombotic 49 Abstract 49 Nucleoside 49 Pharmacodynamics 49 YF Low ENDITEM ls 49 Neuroprotective Effects 49 Zarnestra 49 ASH Annual Meeting 49 Prospective Randomized Trial 49 dual endothelin receptor antagonist 49 Nat Genet 49 Randomised Controlled Trial 49 Choroidal 49 Oral Fingolimod 49 HCV Genotype 49 Homology 49 Mouse Model 49 Decitabine 49 Myelodysplastic Syndromes 49 Cell Lymphoma 49 Immunosuppression 49 Pathologic 49 www.nejm.org 49 Neoplasia 49 ASCO GU 49 SUO 49 Infarct 49 Tumor Progression 48 urothelial carcinoma 48 Ann Intern Med 48 Partial Seizures 48 efavirenz EFV 48 Skeletal Muscle 48 abstr 48 NSABP B 48 #:#-# [033] 48 Arch Neurol 48 Radioimmunotherapy 48 Drug Eluting 48 Cardiostim 48 Clinical Efficacy 48 Adjunctive 48 Hematopoietic Stem Cells 48 Prognostic Significance 48 #:#-# [029] 48 #:# -# [001] 48 Patients Receiving 48 Castration Resistant Prostate Cancer 48 Systemic Sclerosis 48 Transgenic Mice 48 Dendritic Cells 48 Cardiotoxicity 48 ACR ARHP 48 Candesartan 48 Efficacy Study 48 Stent Thrombosis 48 FDG PET imaging 48 Estrogen Receptor 48 Antiviral Activity 48 thymoma 48 Endarterectomy 48 gastrointestinal stromal tumors GIST 48 Lesion 48 Angiogram 48 Pegylated Liposomal Doxorubicin 48 Solid Tumors 48 Phase 2b Study 48 Renal Cell Carcinoma 48 Gastrointestinal Cancers Symposium 48 Endothelial 48 Malignancies 48 Br J Haematol 48 Contrast Agents 48 Clinical Trial Results 48 Pharmacokinetic Study 48 Intracoronary 48 Multiple Myeloma MM 48 metastatic malignant 48 Clinical Outcome 48 Antitumor activity 48 FDG-PET/CT 48 Suppl 47 AACR San Antonio 47 Patients Undergoing 47 adjuvant tamoxifen 47 Differential Diagnosis 47 Environ Health Perspect 47 J Clin Oncol 47 Brain Metastases 47 Epithelium 47 Histological 47 Antigen Specific 47 Adenoma 47 Coronary Artery 47 Bivalirudin 47 Coronary Revascularization 47 #:#-# [031] 47 Nesiritide 47 Histologic 47 Adjuvant Breast Cancer 47 Bortezomib 47 Bosentan 47 leukoencephalopathy 47 YF Low ENDITEM bc 47 Metastatic Renal Cell Carcinoma 47 Capecitabine 47 Acute Ischemic Stroke 47 microsatellite instability 47 RENAL 47 intralesional 47 Immunogenicity 47 Liver Injury 47 Alveolar 47 Liver Failure 47 Carotid Endarterectomy 47 Liver Fibrosis 47 PEG IFN 47 Rheumatoid 47 Capsule Endoscopy 47 restenotic lesions 47 Resection 47 Contraindications 47 Main Outcome Measure 47 gadolinium enhanced 47 Potent Anti 47 Coronary Arteries 47 hepatectomy 47 EBMT criteria 47 Potent Inhibitor 47 radioimmunotherapy RIT 47 FASEB J. 47 Poster Presentation 47 leiomyomas 47 Ranolazine 47 Glioma 47 Invasive Breast Cancer 47 Randomized Clinical Trial 47 Chronic Lymphocytic Leukemia 47 Acute Decompensated Heart Failure 47 Ann Surg 47 Non Alcoholic Fatty 47 Thrombolysis 47 Prolongs Survival 47 Randomized Phase 47 Conjugate 47 ECCO ESMO 47 Myoblast 47 Radiofrequency Ablation RFA 47 Int J Cancer 47 intraepithelial neoplasia 47 Subtypes 47 Plus Ribavirin 47 Node Positive 47 Neurogenic 47 Radiation Induced 47 Fractionated 47 Prolonged Survival 47 Controlled Trial 47 Clinical Trial Data 47 CT Angiography 47 Cyclooxygenase 2 47 Cilostazol 47 Supplementary Appendix 47 Phase 2a Clinical Trial 47 polycythemia vera PV 47 gadolinium enhancing lesions 47 Uterine 47 J Psychopharmacol 47 doi #.# 47 Oncol 47 SCCHN 47 Selective Cardiac Myosin Activator 47 Selective Cardiac Myosin 47 Coronary Artery Bypass Graft 47 substudy 47 Hydroxyurea 47 refractory cutaneous T 47 Anti Inflammatory Drugs 46 Randomized Study 46 Enzastaurin 46 Controlled Study 46 FOLFOX6 46 Antiplatelet 46 Oral Session 46 Laryngoscope 46 Multimodality 46 Improve Survival 46 endoscopic ultrasonography 46 HCV SPRINT 46 Endometrial Cancer 46 Cryoablation 46 Linezolid 46 Arch Dermatol 46 Conjugated 46 B Cell Lymphoma 46 chest radiographs 46 Urinary Catheter 46 Therapeutic Targets 46 Hormone Refractory Prostate Cancer 46 J Fam Pract 46 Oral Presentations 46 CLINICAL PHARMACOLOGY 46 Safinamide 46 SSAO 46 Randomised 46 Microvascular 46 Adjuvant Chemotherapy 46 EuroIntervention 46 AJNR Am J 46 Kidney Transplant Recipients 46 Pharmacokinetics PK 46 Tumor Microenvironment 46 Partial Nephrectomy 46 combretastatin A4 phosphate CA4P 46 Targeted Therapies 46 Abstract Full Text 46 abacavir Ziagen 46 Peritoneal 46 Pharmacokinetics 46 HCV Infection 46 histopathologic findings 46 recurrent GBM 46 chemoradiation therapy 46 Receptor Antagonists 46 Protein Kinase 46 Blind Placebo Controlled Trial 46 Biological Effects 46 Dose Ranging Study 46 cardiac magnetic resonance 46 Multiplexed 46 Endoluminal 46 Phase Ib Clinical Trial 46 YF Low 46 radiotherapy SBRT 46 Myelodysplastic Syndrome MDS 46 Bevacizumab 46 Infarction 46 TPS# [001] 46 Cutaneous 46 Therapeutic Approaches 46 Treating Chronic 46 Study Evaluating 46 Metastatic Prostate Cancer 46 #:#-# [028] 46 Orthostatic Hypotension 46 EINSTEIN DVT 46 Leukocyte 46 sorafenib Nexavar 46 Immunohistochemical 46 Oral Abstract 46 Duodenal 46 Vitro Activity 46 Patency 46 Neoadjuvant 46 Kinase Inhibitors 46 Randomized Controlled Trials 46 Slow Progression 46 Multicenter Trial 46 Recurrent Chest Wall 46 bleomycin 46 S#.# [006] 46 Enoxaparin 46 Hematological 46 CAMMS# 46 Carotid 46 tenofovir disoproxil fumarate TDF 46 Annexin 46 cetuximab Erbitux ® 46 histopathological 46 Insufficiency 46 Br J Cancer 46 Multicenter Study 46 Embolization 46 Leukemias 46 panobinostat 46 Polycythemia Vera 46 #:#-# [023] 46 BERKELEY CA UroToday.com 46 Adefovir 46 Randomized Double Blind Placebo 46 fallopian tube carcinoma 46 CT Colonography 46 metastatic renal cell carcinoma 46 Double Blind Randomized 46 Long Term Outcomes 46 #:#-# [001] 46 Unfractionated Heparin 46 EFNS 46 Oncolytic Reovirus 46 Antitumor Activity 46 Gynecol Oncol 46 Novel Small Molecule 46 Surgical Techniques 46 Prospective Multicenter 46 Patient Outcomes 46 sunitinib Sutent 45 Carcinoma 45 Systolic Blood Pressure 45 Denufosol 45 Prognostic Value 45 Squamous Cell Carcinoma 45 pathologic diagnosis 45 Androgen Receptor 45 F FDG PET 45 ERA EDTA 45 Kidney Function 45 Stenting 45 Myeloid 45 Innate Immunity 45 J Clin 45 transcranial Doppler ultrasound 45 Epratuzumab 45 Oral Cavity 45 Percutaneous Tibial Nerve Stimulation 45 Acute Myocardial Infarction 45 Frontotemporal Dementia 45 computed tomography SPECT imaging 45 #PD 45 Autologous 45 Cochrane Database Syst Rev 45 Dysplasia 45 esophageal carcinoma 45 Adenocarcinoma 45 Fluorouracil 45 Comorbidities 45 Androgen 45 Liver Metastases 45 ^ sup #m 45 TRUS 45 Hernia Repair 45 Doxil ® 45 Long Term Efficacy 45 Oligonucleotides 45 tumor xenograft models 45 Hemodialysis Patients 45 Liver Tumors 45 Relapsed Refractory 45 Systemic Lupus Erythematosus 45 Sagittal 45 Ultrasonography 45 Histopathologic 45 murine model 45 paracentesis 45 Eur Urol 45 Highly Potent 45 HGPIN 45 neoadjuvant treatment 45 papillary thyroid carcinoma 45 Xenograft 45 Gastric Cancer 45 Aortic Stenosis 45 #S #S [002] 45 T1a 45 Exacerbation 45 Protease 45 Venous Thrombosis 45 Ejection Fraction 45 Brentuximab Vedotin SGN 45 Eculizumab 45 Nonsurgical 45 Wegener Granulomatosis 45 Double Blind Placebo 45 bone scintigraphy 45 intraperitoneal injection 45 thyroglobulin 45 verteporfin 45 virological response 45 interstitial pneumonitis 45 See CLINICAL PHARMACOLOGY 45 Breast Ultrasound 45 Renal Artery 45 balloon dilation 45 Chronic Sinusitis 45 digital breast tomosynthesis 45 Endourology 45 Intracerebral Hemorrhage 45 nephrectomy 45 Inactivation 45 Cannabinoid 45 Cell Adhesion 45 Flu Cy 45 ß blockers 45 Tumor Cells 45 Neovascularization 45 trabectedin 45 Well Tolerated 45 Liposomal 45 intestinal metaplasia 45 Tyrosine Kinase Inhibitor 45 Erlotinib 45 epirubicin 45 Non Inferiority 45 Oncogene 45 Tanespimycin 45 Tolerability 45 photocoagulation 45 Carcinomas 45 Sifrol ® 45 Intravascular 45 Am J Cardiol 45 Disease Progression 45 IIIb 45 Skin Structure Infections cSSSI 45 Radiation Dose 45 Advanced Solid Tumors 45 Vasculature 45 Observational Study 45 Revascularization 45 Transcriptome 45 Cancer Res 45 Mesenchymal Stem Cells 45 Statistical Significance 45 Mimetics 45 Soft Tissue Sarcoma 45 CRp 45 Poster Session 45 Inflammatory Arthritis 45 Randomized Comparison 45 Prognostic Factors 45 adjuvant trastuzumab 45 Dasatinib 45 Cancer Vaccines 45 Shows Efficacy 45 extracranial 45 fluvastatin 45 Pulmonary Vein Isolation 45 Preclinical Data 45 Randomized Controlled Trial 45 Postoperative 45 Small Molecule Inhibitors 45 immunocytochemistry 45 Newly Diagnosed 45 Multicenter 45 Cardiac Failure 45 Fluorescein 45 Am Fam Physician 45 transthoracic echocardiography 45 Urologic Nursing 45 Abstract # 45 Mammographic 45 liposome injection 45 Ultrasensitive 45 Microalbuminuria 45 epoetin beta 45 PO# [003] 45 Fingolimod 45 Stent Restenosis 45 Prostate Cancer Progression 45 Angiograms 45 Ectopic 45 Muscle Cells 45 Safety Tolerability 45 Follicular Lymphoma 45 Ventricular Fibrillation 45 Breast Tissue 45 Subgroup Analysis 45 bowel syndrome IBS 45 transarterial chemoembolization 45 transvaginal sonography 45 Scintigraphy 45 reflux esophagitis 45 mRCC 45 Surgical Treatment 45 Transdermal Patch 45 Ablation System 45 Plasmid DNA 45 ABSTRACTS 45 Histologically 45 xenografts 45 Renal Function 45 PMID # [001] 45 adjuvant radiotherapy 45 Intracranial Aneurysms 45 Malignant Melanoma 45 Molecular Basis 45 Metastases 45 Genotypes 45 Embolic 45 Left Ventricular 45 Attenuated 45 TORISEL TM 45 Preimplantation 45 Therapy Shows Promise 45 Adjunctive Therapy 45 Ischaemic 45 Tigecycline 45 Pegylated 45 Angiogenic 45 J Am Coll 45 Fungal Infections 45 HSCT 45 Implantable Cardioverter Defibrillator 45 Endometrial 45 Severe Sepsis 45 Neoadjuvant Chemotherapy 45 Aggressive Reduction 45 Diabetic Neuropathy 45 Salivary 45 Thyroid Cancer 45 Neoplastic 45 Accelerated Partial Breast Irradiation 45 Tumor Response 45 Myocardial Ischemia 45 Somatostatin 45 mucinous 44 Belatacept 44 mycosis fungoides 44 #-# Full Text 44 Phase 2a Trial 44 Symptom Relief 44 Conclusions 44 Carotid Stenting 44 Curr Opin 44 J Urol 44 Optical Coherence Tomography 44 Glycosylation 44 myeloid metaplasia 44 efalizumab 44 Knee Osteoarthritis 44 Apoptotic 44 Treatment Regimen 44 ST Segment Elevation 44 Arimidex Tamoxifen Alone 44 Interferon Beta 44 complement inhibitor eculizumab 44 Subsets 44 Symptom Severity 44 EBUS FNA 44 Catheter Ablation 44 Localized Prostate Cancer 44 Temsirolimus 44 Overactive Bladder 44 Low Dose 44 QT Prolongation 44 Oxidase 44 sipuleucel T 44 Am J Epidemiol 44 Evoked 44 HER2 antibody 44 microvessel 44 Arch Dis Child 44 antibody blinatumomab MT#/MEDI-# 44 fluorescein angiography 44 rFVIIa 44 http:/www.ncbi.nlm.nih.gov/pubmed/# 44 Protease Inhibitor 44 Confirmatory Phase 44 Beta Amyloid 44 II Clinical Trial 44 Nilotinib 44 Arrhythmias 44 Relapsing Multiple Sclerosis 44 surgically resected 44 Molecular Therapy 44 Oncolytic 44 Dissections 44 adjuvant cisplatin 44 Contrast Agent 44 Adjuvant chemotherapy 44 Trigeminal Neuralgia 44 Hsp# Inhibitor 44 Protease Inhibitors 44 assessing T DM1 44 PRNewswire FirstCall NicOx SA 44 Aneurysm Repair 44 ductal adenocarcinoma 44 follicular thyroid cancer 44 Postmarketing 44 Intraoperative 44 aminolevulinic acid ALA 44 Lung Cancer Trial 44 abdominal computed tomography 44 Am J Gastroenterol 44 Amniotic Fluid 44 Polymerase Inhibitor 44 Catheterization 44 Clin Oncol 44 Therapeutic Efficacy 44 Motility 44 Lung Tumors 44 Aggrenox ® 44 ara C 44 colorectal liver metastases 44 prostate cancer mCRPC 44 Clinical Trial Evaluating 44 Evaluable 44 digital subtraction angiography 44 Chemokine Receptor 44 Reduced Incidence 44 eosin 44 Gastrointestinal Stromal Tumors 44 temsirolimus Torisel ® 44 Heart Failure Patients 44 J Nerv Ment Dis 44 conformal radiotherapy 44 bladder carcinoma 44 J Natl Cancer Inst 44 Metvixia 44 Chronic Lymphocytic Leukemia CLL 44 Dermatol 44 dinucleotide 44 HoFH 44 histopathologic examination 44 Keratitis 44 SPECT Single Photon 44 malignant lymphoma 44 USpella 44 RECIST Response Evaluation Criteria 44 MGd 44 Proves Effective 44 Prophylaxis 44 posterolateral fusion 44 Multidisciplinary Approach 44 endoscopic resection 44 #F FDG PET CT 44 bivalirudin monotherapy 44 J Virol 44 Brainstem 44 #:#-# [006] 44 Sentinel Lymph Node Biopsy 44 Investigational Agent 44 Ostomy Wound Management 44 TYKERB 44 cytotoxic therapy 44 Cystectomy 44 TROP 44 Severe Asthma 44 randomized multicenter trial 44 Stomatitis 44 #:#-# [030] 44 Tocilizumab 44 Eur J 44 Endovascular Repair 44 ACE Inhibitor 44 Radiofrequency Ablation 44 Alequel 44 RE LY trial 44 Cortical 44 FOLPI 44 Prostatectomy 44 Metastatic Melanoma 44 Controlled Release 44 IFN α 44 Oropharyngeal 44 Antimicrobial Chemotherapy 44 β blockers 44 Mouse Models 44 chemoradiotherapy 44 Patients Treated 44 Diabetic Nephropathy 44 Novel Inhibitor 44 Deforolimus 44 Anticancer Drugs 44 Pediatric Patients 44 Myocardial 44 gemcitabine Gemzar ® 44 sonographically 44 Abbreviation 44 Dose Reduction 44 #p# [003] 44 Velcade bortezomib 44 HDAC Inhibitor 44 Fondaparinux 44 TLR antagonist 44 rfp cover 44 Predict Response 44 Connective Tissue Oncology 44 Radical Prostatectomy 44 TRANSFORMS 44 Combination Treatment 44 Acute Pancreatitis 44 alfa 2a 44 Clinical Relevance 44 Eur J Cancer 44 Hemorrhagic Stroke 44 Bile Duct 44 Randomized Trials 44 Intracranial 44 Arterial Disease 44 Fibrosis 44 Randomized Placebo Controlled Trial 44 Eur J Neurol 44 thyroid carcinoma 44 Pharmacol Ther 44 MERIT ES 44 Ischemic 44 ® sunitinib malate 44 allogeneic hematopoietic stem cell 44 hRS7 44 Solid Tumours 44 Papillary 44 PET Scans 44 mCi 44 ribavirin Copegus ® 44 Corneal Transplant 44 NOD SCID mice 44 Myocardial Infarction 44 Mammalian Cells 44 Cutaneous T 44 Small Intestine 44 Intervention Trial 44 Immune Tolerance 44 cystic lesions 44 Thrombolytic Therapy 44 immunohistochemical 44 Murine Model 44 UEGW 44 Cerebral Cortex 44 Hodgkin lymphoma HL 44 Small Bowel 44 Cardiovascular Interventions 44 #th Annual Interscience 44 Object Recognition 44 Combination Therapy 44 Nymox NX 44 Abstracts 44 Retroviral 44 ENDO 44 transthoracic 44 Motexafin Gadolinium 44 J Nutr 44 Anticancer Drug 44 inhibitor RG# 44 bullous 44 Lymphoid 44 Anaplastic 44 transgenic mouse models 44 histone deacetylase HDAC inhibitor 44 Epitopes 44 Coronary Artery Bypass Surgery 44 Correlative 44 Lysis 44 Breast Tumors 44 Proteasome 44 Pegylated Interferon 44 leukemia AML 44 Myelodysplastic Syndrome 44 histologic findings 44 Central Retinal Vein 44 Stereotactic Radiosurgery 44 Venous Thromboembolism 44 Non Alcoholic Steatohepatitis 44 tipranavir r 44 Serious Infections 44 Infliximab 44 neoadjuvant therapy 44 Patient Registry 44 Anti Tumor Activity 44 Tumors 44 dose escalation clinical 44 Aromatase Inhibitors 44 boosted protease inhibitor 44 Novel Antibiotic 44 Increased Mortality 44 Preoperative 44 Thrombus 44 Chronic Rhinosinusitis 44 intraperitoneal 44 Arch Intern Med 44 Fallopian Tube 44 TP# mutations 44 cervical lymph nodes 44 Renal Cell Cancer 44 Demonstrates Efficacy 44 Skin Lesions 44 Allogeneic Stem 44 Signaling Pathway 44 ritonavir boosted 44 pituitary adenomas 44 carcinoid tumors 44 Society CTOS 44 PEGylated Fab fragment 44 Breast Cancer Recurrence 44 Hedgehog Pathway Inhibitor 44 FDG PET CT 44 Hypercholesterolemia 44 Hematoma 44 Cardiopulmonary Bypass 44 AJCC 44 Atrial Flutter 44 Response Evaluation Criteria 44 Bioequivalence 44 Cytotoxic 44 vitro cytotoxicity 44 Oral Spray 44 Adjuvant Treatment 44 Nodule 44 Improved Survival 44 Cognitive Impairment 44 Antiplatelet Therapy 44 Pharmacologic 44 epoetin alpha 44 Immunohistochemical analysis 44 EXPAREL ™ 44 RAD# everolimus 44 Ureteral 44 malignant ascites 44 HepaSphere 44 ritonavir boosted lopinavir 44 pancreatic carcinoma 44 Reflux Disease 44 Coronary Lesions 44 TMC# C# 44 Septic Shock 44 seminoma 44 Advanced Melanoma 44 Fast Skeletal Troponin 44 Autoimmune Disorders 44 angiographically 44 Appears Safe 44 Obstet Gynecol 44 Cardiovascular Events 43 Tasigna nilotinib 43 Cochrane Database Syst Rev. 43 Effectively Treats 43 Ann Epidemiol 43 Atrial 43 Allografts 43 Breast Brachytherapy 43 vorinostat 43 Gene Silencing 43 Delayed Graft Function 43 Prospective Randomized 43 TRAIL receptors 43 Angioedema 43 Dyspnea 43 DOXIL 43 recombinant tissue plasminogen 43 Abacavir 43 undergoing radical cystectomy 43 Orally Active 43 Neuroprotection 43 LENALIDOMIDE 43 Non Hodgkin 43 Red Hat alert RHSA 43 Schizophrenia Treatment 43 Intravesical 43 Inflammatory Bowel Diseases 43 Liposomes 43 Anticancer Activity 43 EASL 43 Reproductive Toxicology 43 intravitreal bevacizumab 43 Alzheimers Disease 43 Aggrenox R 43 Epub ahead 43 Shoulder Replacement 43 Vidaza azacitidine 43 Genitourinary Cancers Symposium 43 Torisel temsirolimus 43 Amino Acid 43 T Lymphocytes 43 Decompensated Heart Failure 43 VATS lobectomy 43 Angiographic 43 HER2 Positive Breast Cancer 43 Suboptimal 43 mycophenolate mofetil 43 cinacalcet 43 Inflammatory Markers 43 Metastatic Colorectal Cancer 43 Autoantibodies 43 Ionizing Radiation 43 Cellular Immunotherapy 43 Adjuvant Therapy 43 ASCO Annual Meeting 43 Necrotizing 43 Occluded 43 6 mercaptopurine 43 Newly Diagnosed Multiple Myeloma 43 Platinol ® 43 Arch Pediatr Adolesc Med 43 Protelos R 43 Immune Responses 43 Preclinical Study 43 Lymph Nodes 43 adnexal mass 43 Anastrozole 43 Induction Therapy 43 Imatinib Mesylate 43 malignant pleural mesothelioma 43 obliterans 43 ORENCIA ® 43 Protein Synthesis 43 Non Invasive Treatment 43 ABCSG 43 Tumor Cell 43 Interstitial 43 pleomorphic 43 Angiogenesis 43 Free Full Text 43 Renal Cancer 43 ADA Scientific Sessions 43 Infectivity 43 Pharmacodynamic 43 hedgehog pathway inhibitor 43 Immunomodulatory 43 Previously Treated 43 Aromatase Inhibitor 43 EORTC 43 M#V 43 Phenotype 43 imipramine Tofranil 43 Radiographic 43 Drug Eluting Stents 43 Virus Infection 43 Inhibits 43 brivaracetam 43 liver resection 43 saphenous vein graft 43 Engl J Med 43 Oxidative Stress 43 Myelofibrosis 43 Expedited Review 43 Therapy Reduces 43 T1DM 43 perifosine KRX 43 Am J Ophthalmol 43 Gene Mutations 43 Hematopoietic 43 MR angiography 43 paclitaxel carboplatin 43 #:#-# [035] 43 metastatic carcinoma 43 Survival Benefit 43 Treatment Naïve Patients 43 #:#-# [002] 43 hemodynamic variables 43 Pemetrexed 43 Cardiogenic Shock 43 Proliferative 43 Toxicities 43 Anticancer 43 Trastuzumab Herceptin 43 Hurthle cell 43 HER2 negative 43 Transcatheter 43 Adenomas 43 Xenografts 43 Figure S4 43 thalidomide Thalomid 43 multicenter randomized Phase III 43 bronchoalveolar lavage BAL 43 Critical Limb Ischemia CLI 43 azacytidine 43 Ablation 43 Lipolysis 43 #:# -# [005] 43 Neuropathic Pain 43 Cyclosporine